ARCHIVES

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

This article is from The Cancer Letter archive.

Vol. 11 No. 14 | April 5, 1985

Download PDF Visit The Full Archive

Related Articles

Hawaiian Have Highest Cancer Rate In U.S.

April 29, 1983

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

Max Wicha Describes Michigan’s Restructuring Planning For Growth

May 7, 1999

In Brief: Comprehensive Centers “Jewel In Crown” Of Cancer Program, DeVita Says; Boutwell New NCAB Member

February 18, 1983

NCI Pushes For Hop Concept Review In October; CHOPs Seek Institutions To Volunteer As Evaluations Controls

September 18, 1981

Also Weber returns to M.D. Anderson.

August 8, 2003